The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 28523109 |
79 |
Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4. |
Glaxosmithkline |
| 23886683 |
54 |
The discovery of potent blockers of the canonical transient receptor channels, TRPC3 and TRPC6, based on an anilino-thiazole pharmacophore. |
Glaxosmithkline |
| 31749913 |
50 |
Discovery of a Potent and Selective TRPC5 Inhibitor, Efficacious in a Focal Segmental Glomerulosclerosis Model. |
Goldfinch Bio |
| 30943030 |
97 |
Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases. |
University of Nebraska Medical Center |
| 30335378 |
25 |
Discovery of Pyrrolidine Sulfonamides as Selective and Orally Bioavailable Antagonists of Transient Receptor Potential Vanilloid-4 (TRPV4). |
TBA |
| 29752182 |
52 |
Discovery of a bicyclo[4.3.0]nonane derivative DS88790512 as a potent, selective, and orally bioavailable blocker of transient receptor potential canonical 6 (TRPC6). |
Daiichi Sankyo |
Search and Browse
